Global Cardiac Output Monitoring Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Technology;
Pulmonary Artery Catheter, Thermodilution Pulse Contour Analysis Technique, Lithium Dilution Technique, Arterial Waveform Analysis Technique, Doppler, Transthoracic Impedance & Bioreactance Analysis, and Others.By Product;
Consumables & Accessories, and Devices.By Type;
Invasive, and Non-invasive.By End User;
Hospitals, Ambulatory Surgical Centers, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Cardiac Output Monitoring Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Cardiac Output Monitoring Devices Market was valued at USD 1,413.67 million. The size of this market is expected to increase to USD 1,910.96 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.
The global cardiac output monitoring devices market is a vital segment of the healthcare industry, focused on the continuous assessment and management of a patient’s cardiac output—the amount of blood the heart pumps in a minute. These devices are crucial in evaluating cardiovascular health and are used extensively in hospitals, ambulatory surgical centers, and other healthcare settings to ensure optimal patient care. As cardiovascular diseases (CVDs) remain one of the leading causes of death worldwide, the demand for reliable and accurate cardiac output monitoring has surged, making it a critical tool in the diagnosis and management of heart conditions.
Cardiac output monitoring devices measure various parameters such as heart rate, blood flow, and blood pressure, providing real-time data that helps clinicians make informed decisions during surgical procedures, critical care, and recovery periods. These devices are indispensable in intensive care units (ICUs) and emergency departments, where timely interventions are essential. With technological advancements, the market has seen the rise of both invasive and non-invasive monitoring devices, including wearable and portable systems that can be used in a wider variety of settings, such as home care and outpatient clinics.
The growing focus on patient-centered care, coupled with rising awareness of cardiovascular health, has further accelerated the adoption of cardiac output monitoring devices. Additionally, the development of more advanced, non-invasive, and user-friendly devices has increased their accessibility and ease of use, contributing to their growing demand across various regions. The market is also experiencing innovation driven by advancements in sensor technology, data analytics, and telemedicine, providing more accurate and personalized monitoring solutions.
The global market is influenced by numerous factors, including the increasing prevalence of heart-related diseases, rising healthcare expenditure, and the need for more effective monitoring systems. Moreover, the growing emphasis on early detection, preventive care, and remote patient monitoring are additional drivers of market growth. However, challenges such as high costs, regulatory hurdles, and the complexity of device calibration and usage remain obstacles. Despite these challenges, the cardiac output monitoring devices market continues to expand, offering substantial opportunities for manufacturers, healthcare providers, and patients alike. With the continuous evolution of medical technologies and the increasing demand for advanced healthcare solutions, the global market for cardiac output monitoring devices is poised for significant growth in the coming years.
Global Cardiac Output Monitoring Devices Market Recent Developments
-
In November 2021, Philips announced the acquisition of Cardiologs, a France-based medical technology company. The acquisition is expected to strengthen Philips' existing cardiac diagnostics and monitoring portfolio with Cardiologs' innovative software technology, electrocardiogram (ECG) analysis, and reporting services.
-
In November 2021, GE Healthcare launched the Revolution Apex CT platform, offering scalable detector upgrades from 40 mm to 80 mm or 160 mm without replacing the gantry. It features the world’s fastest gantry speed at 0.23 seconds per rotation.
Segment Analysis
The global cardiac output monitoring devices market is segmented based on device type, technology, end-user, and geography. Each segment plays a vital role in shaping the overall market dynamics and driving growth across various regions.
By device type, the market includes invasive, minimally invasive, and non-invasive monitoring devices. Invasive devices, which typically involve the insertion of a catheter or other instruments, are the most accurate and are commonly used in intensive care units (ICUs) and critical care settings. These devices offer precise measurements of cardiac output, which are crucial for managing critically ill patients. However, non-invasive devices are gaining popularity due to their ease of use, patient comfort, and lower risk of complications. Non-invasive technologies, such as impedance cardiography (ICG) and bioimpedance devices, provide sufficient accuracy for monitoring cardiac output in less critical environments, such as outpatient clinics and home care. Minimally invasive devices, which combine some degree of invasiveness with reduced risks compared to traditional invasive methods, offer a middle ground between the two. These technologies are becoming increasingly attractive due to their balanced approach, which provides accurate results while reducing patient discomfort and complications.
The technology segment of the market is also crucial, with methods such as thermodilution, pulse contour analysis, and Doppler ultrasound playing key roles in determining the performance of cardiac output monitoring devices. Thermodilution, often used with invasive catheters, remains one of the most accurate techniques for monitoring cardiac output in critical care settings. Pulse contour analysis, which measures changes in blood pressure waveforms, and Doppler ultrasound, which measures blood flow velocity, are gaining ground for their non-invasive and minimally invasive features. Technological advancements, such as the integration of artificial intelligence (AI) and real-time data analysis, are driving the next generation of devices to offer more precise and reliable monitoring.
In terms of end-users, hospitals and healthcare centers dominate the market due to the high demand for monitoring critical patients. However, ambulatory surgical centers, homecare settings, and clinics are also emerging as key areas for growth, driven by the demand for outpatient services and home-based healthcare solutions. The increasing preference for home monitoring, especially among elderly patients, is a significant trend that is expected to fuel market expansion in these settings.
Geographically, North America holds the largest market share, owing to its advanced healthcare infrastructure and higher adoption of advanced medical technologies. However, the Asia-Pacific region is expected to witness the fastest growth due to improvements in healthcare systems, rising cardiovascular disease prevalence, and increasing healthcare expenditure. The market is also expanding in Europe, driven by rising awareness and advancements in monitoring technology.
Global Cardiac Output Monitoring Devices Market Analysis
In this report, the global cardiac output monitoring devices market has been segmented by technology, product, type, end user and geography.
Global Cardiac Output Monitoring Devices Market, Segmentation by Technology
The Global Cardiac Output Monitoring Devices Market has been segmented by Technology into Pulmonary Artery Catheter, Thermodilution Pulse Contour Analysis Technique, Lithium Dilution Technique, Arterial Waveform Analysis Technique, Doppler, Transthoracic Impedance & Bioreactance Analysis and Others.
Pulmonary artery catheter technology involves the use of a catheter inserted into the pulmonary artery to directly measure cardiac output. It is one of the most established and widely used methods, particularly in critical care settings, offering precise and continuous monitoring.
Thermodilution pulse contour analysis technique uses the injection of a cold saline solution into the bloodstream and measures the temperature change to calculate cardiac output. It is commonly used in conjunction with advanced monitoring systems to provide real-time, continuous data for hemodynamic monitoring.
Lithium dilution technique is a less invasive method that involves the injection of a lithium-based solution into the bloodstream. By measuring the dilution of lithium in the blood, cardiac output can be calculated. It is often employed in specific clinical situations where other techniques may not be suitable.
Arterial waveform analysis technique uses the analysis of arterial pressure waveforms to estimate cardiac output. It is particularly valued for its ability to provide continuous, real-time data without the need for invasive procedures.
Doppler-based technology uses ultrasound to measure the velocity of blood flow in the heart, arteries, and veins, providing an estimate of cardiac output. It is a widely adopted non-invasive method, especially in outpatient and emergency care settings.
Transthoracic impedance and bioreactance analysis involves measuring changes in the impedance of the chest wall as blood is pumped through the heart. By detecting variations in impedance and bioreactance, the device estimates cardiac output. It is gaining popularity due to its ease of use and minimal patient discomfort.
The others category includes emerging and specialized techniques for cardiac output monitoring that do not fit into the categories above, such as bioimpedance and electromagnetic methods. These technologies are often under research or used in specific clinical applications.
Each of these technologies offers distinct advantages in terms of accuracy, invasiveness, and clinical application, contributing to the diverse range of options available in the global cardiac output monitoring devices market. The choice of technology typically depends on factors such as the patient's condition, the clinical setting, and the desired monitoring duration.
Global Cardiac Output Monitoring Devices Market, Segmentation by Product
The Global Cardiac Output Monitoring Devices Market has been segmented by Product into Consumables & Accessories and Devices.
The consumables & accessories segment includes various components that are essential for the proper functioning and maintenance of monitoring devices, such as sensors, electrodes, and catheters. These consumables play a crucial role in ensuring continuous monitoring and accurate data collection, often requiring frequent replacement to maintain optimal device performance. As the demand for cardiac output monitoring devices grows, so does the need for consumables, which contributes to the steady revenue stream in the market.
The devices segment comprises the actual monitoring equipment used to measure and assess cardiac output, including invasive, minimally invasive, and non-invasive devices. These devices vary in terms of technology, complexity, and application, with non-invasive and portable devices gaining traction due to their ease of use and patient comfort. Invasive devices are typically used in critical care settings, offering high accuracy, while minimally invasive devices provide a balance between accuracy and patient safety. The devices segment is expected to continue evolving with advancements in technology, offering opportunities for greater precision and wider adoption in clinical settings and home care environments.
Global Cardiac Output Monitoring Devices Market, Segmentation by Type
The global cardiac output monitoring devices market has been segmented by type into invasive and non-invasive devices.
Invasive devices are typically used in clinical settings where precise and continuous monitoring is required. These devices involve the insertion of a catheter or sensor into the patient's body to directly measure cardiac output. While they provide highly accurate and reliable readings, invasive devices carry certain risks, such as infection or complications associated with the insertion process. These devices are commonly used in intensive care units (ICUs), during major surgeries, and for patients with severe cardiac conditions that require close monitoring.
Non-invasive devices, on the other hand, offer an alternative that does not require penetration of the skin or body. These devices use external sensors or technologies, such as ultrasound, bioimpedance, or Doppler measurements, to estimate cardiac output without the need for invasive procedures. Non-invasive devices have gained popularity due to their safety, ease of use, and ability to be applied in a wider range of settings, including outpatient clinics, home care, and emergency departments. They offer a less invasive, more comfortable monitoring experience for patients, and advancements in technology have made them increasingly accurate and reliable for clinical use. As healthcare continues to shift towards more patient-friendly and cost-effective solutions, the non-invasive segment is expected to grow significantly in the coming years.
Global Cardiac Output Monitoring Devices Market, Segmentation by End User
The global cardiac output monitoring devices market has been segmented by end user into hospitals, ambulatory surgical centers, and others.
Hospitals are the largest end user segment due to their advanced infrastructure and the high demand for cardiac monitoring in critical care units such as intensive care units (ICUs) and emergency departments. The need for continuous monitoring of patients with cardiovascular diseases, particularly in high-risk scenarios like post-surgery recovery and heart failure management, drives the significant usage of cardiac output monitoring devices in hospitals.
Ambulatory surgical centers are also a growing segment in the market. These centers, which focus on outpatient surgeries, require efficient and accurate monitoring of patients during and after procedures. Cardiac output monitoring devices are increasingly being used in these settings to ensure patient safety, especially during surgeries that may involve anesthesia or other procedures affecting cardiac function. The growing trend toward outpatient and same-day discharge surgeries is contributing to the expansion of this segment.
The "others" category includes various other healthcare settings, such as home care and remote monitoring environments, where portable or user-friendly cardiac output devices are utilized for ongoing management of patients with cardiovascular conditions. This segment is experiencing growth due to the increasing adoption of telemedicine, remote patient monitoring, and the rising demand for at-home healthcare solutions. The expansion of healthcare services in emerging markets is also contributing to the growth of this segment, providing more opportunities for cardiac output monitoring devices in diverse care settings.
Global Cardiac Output Monitoring Devices Market, Segmentation by Geography
In this report, the Global Cardiac Output Monitoring Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Cardiac Output Monitoring Devices Market Share (%), by Geographical Region, 2024
The market for cardiac output monitoring devices expanded significantly over the past few years. Cardiac output, which refers to the amount of blood the heart pumps each minute, was measured through cardiac output monitoring equipment. The rising prevalence of cardiovascular diseases (CVDs) and the ageing population were the primary factors driving the demand for these devices.
The North American market generated the highest portion of revenue during the projected period, driven by the high prevalence of CVDs and the availability of advanced medical services in the region. The market growth in North America was also fueled by the increasing use of technologically advanced cardiac output monitoring devices. Additionally, government programs aimed at strengthening the region’s healthcare infrastructure and rising healthcare costs contributed to the growing demand for these devices.
The Asia Pacific market, on the other hand, experienced the greatest revenue CAGR during the same period. The rising frequency of CVDs and the ageing populations in countries like China and Japan played a significant role in driving market expansion in this region. The growth of the cardiac output monitoring devices market in Asia Pacific was also supported by increasing disposable incomes and the rising adoption of advanced medical technologies. Moreover, the availability of affordable cardiac output monitoring devices in the region further contributed to the market’s expansion.
In Europe, a moderate rate of market growth was observed. The region had a large ageing population and a high prevalence of CVDs. The uptake of advanced medical technologies in Europe was driving market expansion, with increasing healthcare spending and government efforts to upgrade healthcare infrastructure playing key roles in boosting the demand for cardiac output monitoring devices.
In conclusion, the global market for cardiac output monitoring devices saw significant growth, with North America and Asia Pacific emerging as the key growth drivers. The rising incidence of CVDs and the ageing population were the primary factors contributing to market expansion. Additionally, the availability of affordable cardiac output monitoring tools supported the market’s growth, especially in developing countries.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Cardiac Output Monitoring Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising prevalence of cardiovascular diseases and related complications
- Increasing demand for early detection and continuous monitoring of cardiac health
-
Advancements in cardiac output monitoring technology, such as non-invasive devices - Advancements in cardiac output monitoring technology, particularly the development of non-invasive devices, have been a significant driver of growth in the global cardiac output monitoring devices market. Traditionally, cardiac output monitoring required invasive procedures, such as the insertion of a catheter into the bloodstream, to measure parameters like blood flow and pressure. These methods, while accurate, come with risks of complications, longer recovery times, and increased healthcare costs.
Non-invasive cardiac output monitoring devices have revolutionized this process by enabling accurate measurement of cardiac function without the need for invasive procedures. These devices use advanced technologies like bioimpedance, Doppler ultrasound, and transcutaneous sensors to measure heart performance through the skin or external body surfaces. This makes monitoring less invasive, safer, and more comfortable for patients, leading to wider acceptance and adoption in clinical settings.
The advantages of non-invasive cardiac output monitoring include faster and easier deployment, reduced risk of infection or complications, and the ability to monitor patients more frequently without the burden of invasive procedures. Additionally, these devices are often portable and user-friendly, making them suitable for use in a variety of settings, including intensive care units, emergency departments, and even at-home monitoring. As a result, healthcare providers can continuously track a patient's cardiac status, making it easier to detect early signs of deterioration and optimize treatment decisions in real-time.
The growing focus on improving patient outcomes and reducing hospital stays further drives the adoption of non-invasive cardiac output monitoring devices. By providing continuous and real-time data, these devices allow clinicians to make more informed decisions, ultimately improving patient care and reducing healthcare costs. The technological advancements in non-invasive monitoring are expected to continue shaping the future of cardiac care, making it a key factor driving the market’s growth.
Restraints
- High cost of advanced cardiac output monitoring devices
- Limited reimbursement policies for certain cardiac monitoring technologies
-
Complexity and technical challenges in device calibration and use - The complexity and technical challenges in device calibration and use present a significant restraint in the global cardiac output monitoring devices market. While advancements in cardiac output monitoring technology, including non-invasive devices, have improved patient care and monitoring, these devices still face technical hurdles that can impact their widespread adoption and effectiveness.
One of the primary challenges is the calibration process. Cardiac output monitoring devices must be calibrated accurately to ensure precise and reliable measurements of heart function. Calibration can be a complex and time-consuming process, often requiring skilled technicians or healthcare professionals with specialized knowledge to ensure that the device provides accurate readings. Inaccurate calibration can lead to misleading results, potentially affecting clinical decision-making and patient outcomes.
Moreover, the use of cardiac output monitoring devices, particularly more advanced and non-invasive ones, can also be technically demanding. Healthcare professionals may require extensive training to operate these devices effectively, as they often come with sophisticated features and settings. Improper use or misinterpretation of data can lead to errors in diagnosis or treatment. This is especially true in fast-paced clinical environments, such as intensive care units (ICUs), where staff may be under pressure to monitor multiple patients simultaneously.
Another technical challenge lies in the integration of these devices with existing healthcare systems. Cardiac output monitoring devices need to be compatible with hospital networks, electronic health records (EHR), and other monitoring systems. Ensuring seamless integration can be difficult, particularly in settings with legacy systems or limited technical infrastructure.
These complexities and technical challenges can create barriers to the widespread use of cardiac output monitoring devices, especially in smaller healthcare settings or regions with limited access to trained professionals. Additionally, the need for ongoing maintenance and calibration increases operational costs, which can be a deterrent for hospitals and clinics with limited budgets.
Opportunities
- Expansion of healthcare infrastructure in emerging markets
- Integration of artificial intelligence and data analytics for enhanced monitoring
-
Development of portable and user-friendly monitoring solutions - The development of portable and user-friendly monitoring solutions presents a significant opportunity for growth in the global cardiac output monitoring devices market. As healthcare continues to evolve towards more accessible, patient-centric care models, there is a growing demand for devices that can be easily used outside of traditional hospital settings, such as in outpatient clinics, home care, or even remote locations.
Portable cardiac output monitoring devices allow for continuous or frequent monitoring of patients’ cardiac health, without the need for patients to be confined to a hospital or clinic. These devices are typically smaller, lighter, and more compact than traditional systems, making them ideal for use in a variety of environments. For example, patients with chronic cardiovascular conditions can benefit from home-based monitoring, allowing healthcare providers to track their cardiac status regularly without the need for frequent hospital visits. This can lead to better disease management, earlier detection of complications, and a reduction in hospital readmissions.
User-friendly features also play a key role in making cardiac output monitoring more accessible. Devices with intuitive interfaces, clear visual displays, and automated functions can be easily operated by healthcare professionals with minimal training or even by patients themselves in some cases. This accessibility reduces the likelihood of errors due to improper use and empowers patients to take an active role in managing their health. Furthermore, as the healthcare industry embraces telemedicine and remote monitoring, portable and user-friendly devices become increasingly important for ensuring that clinicians can receive real-time data from patients without requiring in-person visits.
Moreover, the portability of these devices enhances their application in emergency and intensive care settings, where timely and accurate cardiac output monitoring is critical. By providing healthcare professionals with real-time data in a more flexible, accessible format, portable solutions can improve patient outcomes, enhance workflow efficiency, and lower the costs associated with continuous in-hospital monitoring.
The growing trend towards home healthcare, increased awareness of the benefits of remote monitoring, and the shift toward personalized healthcare solutions make portable and user-friendly cardiac output monitoring devices an exciting opportunity for the market. As technology continues to advance, these devices are likely to become more sophisticated, cost-effective, and accessible, offering new possibilities for patient care and market expansion.
Competitive Landscape Analysis
Key players in Global Cardiac Output Monitoring Devices Market include:
- GE Healthcare
- Getinge AB
- Edward Lifesciences Corporation
- Baxter International Inc.
- LiDCO Group plc
- ICU Medical, Inc.
- Deltex Medical Group plc
- Uscom
- CNSystems Medizintechnik GmbH
- Osypka Medical GmbH
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Cardiac Output Monitoring Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising prevalence of cardiovascular diseases and related complications.
- Increasing demand for early detection and continuous monitoring of cardiac health.
- Advancements in cardiac output monitoring technology, such as non-invasive devices.
- Restraints
- High cost of advanced cardiac output monitoring devices.
- Limited reimbursement policies for certain cardiac monitoring technologies.
- Complexity and technical challenges in device calibration and use.
- Opportunities
- Expansion of healthcare infrastructure in emerging markets.
- Integration of artificial intelligence and data analytics for enhanced monitoring.
- Development of portable and user-friendly monitoring solutions.
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Cardiac Output Monitoring Devices Market, By Technology, 2021 - 2031 (USD Million)
- Pulmonary Artery Catheter
- Thermodilution Pulse Contour Analysis Technique
- Lithium Dilution Technique
- Arterial Waveform Analysis Technique
- Doppler
- Transthoracic Impedance & Bioreactance Analysis
- Others
- Global Cardiac Output Monitoring Devices Market, By Product, 2021 - 2031 (USD Million)
- Consumables & Accessories
- Devices
- Global Cardiac Output Monitoring Devices Market, By Type, 2021 - 2031 (USD Million)
- Invasive
- Non-invasive
- Global Cardiac Output Monitoring Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global Cardiac Output Monitoring Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Cardiac Output Monitoring Devices Market, By Technology, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- GE Healthcare
- Getinge AB
- Edward Lifesciences Corporation
- Baxter International Inc.
- LiDCO Group plc
- ICU Medical, Inc.
- Deltex Medical Group plc
- Uscom
- CNSystems Medizintechnik GmbH
- Osypka Medical GmbH
- Company Profiles
- Analyst Views
- Future Outlook of the Market